InsiderClue
Insiders · Profile

Washington Robin L

Director at Salesforce · Director at Vertiv · EVP, CFO at Gilead Sciences. Filing since 7 Feb 2012. CIK 0001327145

CRM Salesforce Director · 2 trades VRT Vertiv Director · 1 trade GILD Gilead Sciences EVP, CFO · 46 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CRM Salesforce
28 Feb 2025
Director
Bought
1,695
$499.36K
4.1%
VRT Vertiv
19 Nov 2024
Director
Sold on a plan
5,000
$673.51K
50.0%
CRM Salesforce
21 Mar 2019
Director
Sold, plan not stated
7,634
$1.26M
20.2%
GILD Gilead Sciences
28 Feb 2018
EVP, CFO
Sold, plan not stated
5,000
$401.57K
4.5%
GILD Gilead Sciences
7 Sep 2017
EVP, CFO
Sold, plan not stated
33,750
$2.87M
77.9%
GILD Gilead Sciences
7 Sep 2017
EVP, CFO
Sold, plan not stated
18,070
$1.54M
14.9%
GILD Gilead Sciences
16 Feb 2016
EVP, CFO
Sold, plan not stated
6,250
$567.00K
6.9%
GILD Gilead Sciences
2 Nov 2015
EVP, CFO
Sold, plan not stated
6,250
$684.15K
6.6%
GILD Gilead Sciences
2 Sep 2015
EVP, CFO
Sold, plan not stated
6,250
$638.78K
6.2%
GILD Gilead Sciences
1 May 2015
EVP, CFO
Sold, plan not stated
16,842
$1.77M
37.8%
GILD Gilead Sciences
2 Feb 2015
EVP, CFO
Sold, plan not stated
33,192
$3.50M
40.0%
GILD Gilead Sciences
3 Nov 2014
EVP, CFO
Sold, plan not stated
33,192
$3.66M
40.0%
GILD Gilead Sciences
25 Aug 2014
EVP, CFO
Sold, plan not stated
4,304
$455.66K
9.2%
GILD Gilead Sciences
14 Aug 2014
EVP, CFO
Sold, plan not stated
33,556
$3.21M
40.2%
GILD Gilead Sciences
1 Aug 2014
EVP, CFO
Sold, plan not stated
30,600
$2.80M
38.0%
GILD Gilead Sciences
30 Jun 2014
EVP, CFO
Sold, plan not stated
10,400
$873.40K
18.2%
GILD Gilead Sciences
4 Jun 2014
EVP, CFO
Sold, plan not stated
6,426
$530.27K
10.1%
GILD Gilead Sciences
6 May 2014
EVP, CFO
Sold, plan not stated
3,000
$239.73K
5.7%
GILD Gilead Sciences
1 May 2014
EVP, CFO
Sold, plan not stated
27,600
$2.18M
35.6%
GILD Gilead Sciences
28 Feb 2014
EVP, CFO
Sold, plan not stated
30,600
$2.56M
38.0%
GILD Gilead Sciences
21 Feb 2014
EVP, CFO
Sold, plan not stated
5,000
$416.22K
9.1%
GILD Gilead Sciences
19 Feb 2014
EVP, CFO
Sold, plan not stated
968
$80.69K
1.9%
GILD Gilead Sciences
2 Jan 2014
SVP, CFO
Sold, plan not stated
35,600
$2.67M
100%
GILD Gilead Sciences
6 Nov 2013
SVP, CFO
Sold, plan not stated
2,869
$196.91K
11.2%
GILD Gilead Sciences
30 Sep 2013
SVP, CFO
Sold, plan not stated
35,600
$2.25M
56.8%
GILD Gilead Sciences
1 Jul 2013
SVP, CFO
Sold, plan not stated
45,600
$2.37M
62.7%
GILD Gilead Sciences
11 Apr 2013
SVP, CFO
Sold, plan not stated
968
$48.59K
3.4%
GILD Gilead Sciences
1 Apr 2013
SVP, CFO
Sold, plan not stated
13,000
$628.33K
31.6%
GILD Gilead Sciences
27 Mar 2013
SVP, CFO
Sold, plan not stated
45,000
$2.12M
61.6%
GILD Gilead Sciences
14 Mar 2013
SVP, CFO
Sold, plan not stated
4,304
$197.32K
13.3%
GILD Gilead Sciences
5 Mar 2013
SVP, CFO
Sold, plan not stated
45,000
$2.00M
65.4%
GILD Gilead Sciences
4 Mar 2013
SVP, CFO
Sold, plan not stated
9,800
$428.05K
29.2%
GILD Gilead Sciences
28 Jan 2013
SVP, CFO
Sold, plan not stated
11,550
$456.02K
33.6%
GILD Gilead Sciences
12 Nov 2012
SVP, CFO
Sold, plan not stated
27,975
$2.05M
71.0%
GILD Gilead Sciences
7 Nov 2012
SVP, CFO
Sold, plan not stated
4,099
$271.76K
26.4%
GILD Gilead Sciences
31 Oct 2012
SVP, CFO
Sold, plan not stated
2,925
$197.82K
20.4%
GILD Gilead Sciences
24 Oct 2012
SVP, CFO
Sold, plan not stated
625
$42.78K
5.2%
GILD Gilead Sciences
22 Oct 2012
SVP, CFO
Sold, plan not stated
7,650
$506.13K
40.1%
GILD Gilead Sciences
2 Oct 2012
SVP, CFO
Sold, plan not stated
14,750
$1.01M
56.4%
GILD Gilead Sciences
18 Sep 2012
SVP, CFO
Sold, plan not stated
4,500
$302.63K
28.3%
GILD Gilead Sciences
17 Sep 2012
SVP, CFO
Sold, plan not stated
57,250
$3.71M
83.4%
GILD Gilead Sciences
10 Sep 2012
SVP, CFO
Sold, plan not stated
9,000
$538.02K
44.1%
GILD Gilead Sciences
30 Aug 2012
SVP, CFO
Sold, plan not stated
3,466
$199.24K
23.3%
GILD Gilead Sciences
2 Aug 2012
SVP, CFO
Sold, plan not stated
29,500
$1.70M
66.5%
GILD Gilead Sciences
27 Jul 2012
SVP, CFO
Sold, plan not stated
2,888
$159.85K
20.2%
GILD Gilead Sciences
20 Jul 2012
SVP, CFO
Sold, plan not stated
4,331
$230.68K
27.5%
GILD Gilead Sciences
20 Apr 2012
SVP, CFO
Sold, plan not stated
4,331
$226.35K
28.9%
GILD Gilead Sciences
16 Mar 2012
SVP, CFO
Sold, plan not stated
7,998
$373.54K
42.8%
GILD Gilead Sciences
7 Feb 2012
SVP, CFO
Sold, plan not stated
25,000
$1.38M
70.1%
49 decisions on file.